A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient
RENAL FAILURE, vol.29, no.1, pp.103-105, 2007 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 29 Issue: 1
- Publication Date: 2007
- Doi Number: 10.1080/08860220601039528
- Journal Name: RENAL FAILURE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.103-105
- Hacettepe University Affiliated: Yes
Abstract
Renal transplant recipients are susceptible to Kaposi's sarcoma (KS) because of treatment with immunosuppressive drugs. Sirolimus, a new immunosuppressive agent, has been successfully used for immune-suppression in kidney transplant recipients. Several studies have shown the potential role of sirolimus to inhibit progression of KS in kidney-transplant recipients. This report details a kidney-transplant recipient with cutaneous KS who had a complete remission in response to sirolimus therapy.